InsidersTradesSigma
Track the 티앤알바이오팹 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 티앤알바이오팹 has recorded 11 public disclosures. Market capitalisation: €115.3bn. The latest transaction was reported on 14 July 2026 (Other). Among the most active insiders: 윤원수. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
티앤알바이오팹 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se enfoca en el desarrollo de tecnologías y soluciones de bioimpresión para la medicina regenerativa.